본문 바로가기

Multicenter retrospective analysis of patients with chronic lymphocytic leukemia in Korea

문서 유형
연구출판물 · 학술지 논문
등재
ESCIKCIScopus
저널 순위
Scopus Q3KCI Q3
저널
Blood Research56(4) · pp.243 · 2021
피인용
Scopus 6KCI 2
FWCI (Scopus)
0.23
JCR IF
JCR 2020 0
ISSN
2287-979X

저자

  1. Yi, Jun Ho제1저자Division of Hematology-Oncology, Department of Medicine, Chung-Ang University Hospital, Seoul, Korea
  2. Lee, Gyeong-WonDivision of Hematology-Oncology, Department of Internal Medicine, Institute of Health Science, Gyeongsang National University Hospital, Gyeongsang National University College of Medicine, Jinju, Korea
  3. Lee, Ji HyunDepartment of Internal Medicine, Dong-A University College of Medicine, Busan, Korea
  4. Yoo, Kwai HanDivision of Hematology-Oncology, Gachon University College of Medicine, Incheon, Korea
  5. Jung, Chul WonDepartment of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
  6. Kim, Dae SikDepartment of Internal Medicine, Korea University Guro Hospital, Seoul, Korea
  7. Lee, Jeong-OkDivision of Hematology-Oncology, Seoul National University Bundang Hospital, Seongnam, Korea
  8. Eom, Hyeon SeokNational Cancer Center, Goyang, Korea
  9. Byun, Ja MinDivision of Hematology-Oncology, Seoul National University Hospital, Seoul, Korea
  10. Koh, YoungilDivision of Hematology-Oncology, Seoul National University Hospital, Seoul, Korea
  11. Yoon, Sung SooDivision of Hematology-Oncology, Seoul National University Hospital, Seoul, Korea
  12. Kim, Jin SeokDivision of Hematology, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea
  13. Kong, Jee HyunDivision of Hematology-Oncology, Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea
  14. Yhim, Ho-YoungDepartment of Internal Medicine, Jeonbuk National University Medical School, Jeonju, Korea
  15. Yang, Deok-HwanDepartment of Hematology-Oncology, Chonnam National University Hwasun Hospital, Gwangju, Korea
  16. Yoon, Dok HyunDepartment of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
  17. Lim, Do HyoungDivision of Hematology-Oncology, Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea
  18. Lee, Won-SikInje University Busan Paik Hospital
  19. 신호진교신저자Division of Hematology-Oncology, Department of Internal Medicine, School of Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Korea

초록

© 2021 Korean Society of Hematology.Background Chronic lymphocytic leukemia (CLL) is the most common type of adult leukemia in Western countries but is rare in the East Asian countries. Due to its rarity and the lack of feasible novel agents and laboratory prognostic tools, there are limited data on the clinical outcomes of this disease in Asia. To clarify the current treatment status, we performed a multicenter retrospective analysis of patients with CLL in Korea. Methods The medical records of 192 eligible patients between 2008 and 2019 were reviewed for clinical characteristics, treatment courses, and outcomes. The first-line treatment regimens of the patients included in this analysis were as follows: fludarabine/cyclophosphamide/rituximab (FCR) (N=117, 52.7%), obinutuzumab plus chlorambucil (GC) (N=30, 13.5%), and chlorambucil monotherapy (N=24, 10.8%). Results The median progression-free survival (PFS) was 55.6 months, and the average 2-year PFS rate was 80.3%. PFS was not significantly different between the patients receiving FCR and those receiving GC; however, chlorambucil treatment was associated with significantly inferior PFS (P <0.001). The median overall survival was 136.3 months, and the average 5- and 10-year OS rates were 82.0% and 57.4%, respectively. Conclusion This is one of the largest studies involving Korean patients with CLL. Although the patients had been treated with less favored treatment regimens, the outcomes were not different from those reported in Western studies.

키워드

AsiaChronic lymphocytic leukemiaOutcomes

식별자

Scopus EID
2-s2.0-85123345847
KCI
ART002787662